| # | SS Date | SS Time | Ago | Actual Date | Actual Time | Company | News | Category | CMP | Action/View | Analysis/Notes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 56 | 2026-05-16 | 12:39:24 | 1h ago | 2026-05-16 | 11:39:24 | AARTI DRUGS | Q4 EBITDA 877M vs 933M (YoY), Margin 12.18% vs 13.8% | Results | CAUTION | Margin contraction, EBITDA dips | |
| 67 | 2026-05-16 | 12:57:52 | — | 2026-05-16 | 12:57:52 | AARTI DRUGS | Q4 Cons Net Profit 552M vs 629M (YoY), Revenue 7.2B vs 6.77B | Results | CAUTION | Profit declines ~12% YoY |
| # | SS Date | SS Time | Ago | Actual Date | Actual Time | Company | News | Category | CMP | Action/View | Analysis/Notes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 29 | 2026-05-16 | 12:37:14 | 2h ago | 2026-05-16 | 10:37:14 | ARIANT SUPERSTRUCTURES | Q4 EBITDA 302M vs 220M (YoY), Margin 16.72% vs 14.41% | Results | BUY | Margin expansion, EBITDA strong |
| # | SS Date | SS Time | Ago | Actual Date | Actual Time | Company | News | Category | CMP | Action/View | Analysis/Notes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 18 | 2026-05-16 | 12:21:05 | 23m ago | 2026-05-16 | 11:58:05 | Arvind Limited | Expects revenue growth in double digits for FY27 | Guidance | BUY | Double-digit revenue guidance positive | |
| 59 | 2026-05-16 | 12:39:59 | 1h ago | 2026-05-16 | 11:39:59 | Arvind Limited | Q4 Cons Net Profit 1.6B vs 1.51B (YoY), Revenue 25.53B vs 22.2B | Results | POSITIVE | Profit +6%, steady growth | |
| 62 | 2026-05-16 | 12:57:21 | 2h ago | 2026-05-16 | 10:57:21 | Arvind Limited | Recommends final dividend of 4.50 rupees per share | Dividend | POSITIVE | Dividend announced, shareholder return | |
| 69 | 2026-05-16 | 12:57:52 | — | 2026-05-16 | 12:57:52 | Arvind Limited | Q4 EBITDA 3B vs 2.45B (YoY), Margin 12% vs 11.1% | Results | POSITIVE | Margin expansion, operational strength |
| # | SS Date | SS Time | Ago | Actual Date | Actual Time | Company | News | Category | CMP | Action/View | Analysis/Notes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 87 | 2026-05-16 | 16:24:23 | 3h ago | 2026-05-16 | 13:24:23 | Aurobindo Pharma | Co subsidiary CuraTeQ Biologics receives CDSCO marketing authorisation | Regulatory | POSITIVE | Regulatory approval for biologics |
| # | SS Date | SS Time | Ago | Actual Date | Actual Time | Company | News | Category | CMP | Action/View | Analysis/Notes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 55 | 2026-05-16 | 12:39:24 | 1h ago | 2026-05-16 | 11:39:24 | AZAD ENGINEERING | Q4 EBITDA 577M vs 454M (YoY), Margin 36.68% vs 36.47% | Results | POSITIVE | EBITDA +27%, stable margin | |
| 66 | 2026-05-16 | 12:57:43 | — | 2026-05-16 | 12:57:43 | AZAD ENGINEERING | Q4 Net Profit 351M vs 260M (YoY), Revenue 1.6B vs 1.25B | Results | BUY | Profit +35%, strong show |
| # | SS Date | SS Time | Ago | Actual Date | Actual Time | Company | News | Category | CMP | Action/View | Analysis/Notes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 31 | 2026-05-16 | 12:37:14 | 2h ago | 2026-05-16 | 10:37:14 | BAJAJ ELECTRICAL | Q4 EBITDA 431M vs 930M (YoY), Margin 3.48% vs 7.35% | Results | CAUTION | Sharp margin contraction, weak EBITDA |
| # | SS Date | SS Time | Ago | Actual Date | Actual Time | Company | News | Category | CMP | Action/View | Analysis/Notes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 7 | 2026-05-16 | 12:11:54 | 18m ago | 2026-05-16 | 11:53:54 | BALRAMPUR CHINI MILLS | Q4 EBITDA 2.84B vs 3.65B (YoY), Margin 17.75% vs 24.3% | Results | CAUTION | Margin erodes significantly | |
| 12 | 2026-05-16 | 12:12:01 | — | 2026-05-16 | 12:12:01 | BALRAMPUR CHINI MILLS | Q4 Cons Net Profit 1.6B vs 2.3B (YoY), Revenue 16B | Results | CAUTION | Profit down ~30% YoY |
| # | SS Date | SS Time | Ago | Actual Date | Actual Time | Company | News | Category | CMP | Action/View | Analysis/Notes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 13 | 2026-05-16 | 12:12:18 | — | 2026-05-16 | 12:12:18 | China, US | Plan to create trade and investment councils, says Xinhua | Geopolitical | POSITIVE | Trade cooperation boosts sentiment |
| # | SS Date | SS Time | Ago | Actual Date | Actual Time | Company | News | Category | CMP | Action/View | Analysis/Notes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 60 | 2026-05-16 | 12:39:59 | 1h ago | 2026-05-16 | 11:39:59 | COCHIN SHIPYARD | Q4 EBITDA 3.1B vs 2.53B (YoY), Margin 20.87% vs 15.35% | Results | BUY | Margin expansion, strong EBITDA | |
| 65 | 2026-05-16 | 12:57:43 | — | 2026-05-16 | 12:57:43 | COCHIN SHIPYARD | Q4 Net Profit 2.76B vs 2.85B (YoY); Est 2.85B | Results | HOLD | Profit in line with estimates |
| # | SS Date | SS Time | Ago | Actual Date | Actual Time | Company | News | Category | CMP | Action/View | Analysis/Notes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 43 | 2026-05-16 | 12:38:35 | — | 2026-05-16 | 12:38:35 | Container Corp | Signs agreement with PSA Mumbai for rail cargo transport | Partnership | POSITIVE | Rail cargo boost, operational synergy |
| # | SS Date | SS Time | Ago | Actual Date | Actual Time | Company | News | Category | CMP | Action/View | Analysis/Notes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 9 | 2026-05-16 | 12:11:54 | 18m ago | 2026-05-16 | 11:53:54 | Cupid Limited | Aims for ₹600 Cr revenue and ₹180 Cr net profit by FY27 with over 30% net margins | Guidance | BUY | Aggressive growth targets | |
| 63 | 2026-05-16 | 12:57:21 | 2h ago | 2026-05-16 | 10:57:21 | Cupid Limited | Q4 EBITDA 463M vs 135M (YoY), Margin 38.6% vs 23.81% | Results | BUY | Margin expansion, stellar EBITDA growth |
| # | SS Date | SS Time | Ago | Actual Date | Actual Time | Company | News | Category | CMP | Action/View | Analysis/Notes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 64 | 2026-05-16 | 12:57:43 | — | 2026-05-16 | 12:57:43 | DOW JONES | Down 330.12 points (-0.66%) at 49,733.34 after market open | Macro | CAUTION | US market weakness early session | |
| 75 | 2026-05-16 | 12:58:43 | — | 2026-05-16 | 12:58:43 | DOW JONES | Unofficially closes down 517.28 points (-1.03%) at 49,546.18 | Macro | CAUTION | US market selloff intensifies |
| # | SS Date | SS Time | Ago | Actual Date | Actual Time | Company | News | Category | CMP | Action/View | Analysis/Notes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 101 | 2026-05-20 | 12:42:18 | — | 2026-05-20 | 12:42:18 | AMAGI MEDIA LABS | Q4 CONS NET PROFIT 343M RUPEES VS LOSS 106M (YOY) | Results | POSITIVE | Strong turnaround, profit vs loss | |
| 102 | 2026-05-20 | 12:42:18 | — | 2026-05-20 | 12:42:18 | AMAGI MEDIA LABS | Q4 EBITDA GAIN 238M RUPEES VS LOSS 132M (YOY), Margin 6% | Results | POSITIVE | EBITDA positive, operational recovery |
| # | SS Date | SS Time | Ago | Actual Date | Actual Time | Company | News | Category | CMP | Action/View | Analysis/Notes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 201 | 2026-05-20 | 19:28:17 | 9m ago | 2026-05-20 | 19:19:17 | JNK | Q4 EBITDA 420M RUPEES VS 148M (YOY), Q4 EBITDA MARGIN 14% VS 7.83% | Results | BUY | Robust margin expansion, EBITDA surge | |
| 202 | 2026-05-20 | 19:28:17 | 11m ago | 2026-05-20 | 19:17:17 | JNK | Q4 SL NET PROFIT 317M RUPEES VS 133M (YOY), REVENUE 3B VS 1.9B | Results | BUY | Profit +138%, revenue growth |
| # | SS Date | SS Time | Ago | Actual Date | Actual Time | Company | News | Category | CMP | Action/View | Analysis/Notes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 211 | 2026-05-20 | 19:28:26 | — | 2026-05-20 | 19:28:26 | COSMO FIRST | Q4 EBITDA 1.1B RUPEES VS 703M (YOY), Q4 EBITDA MARGIN 11% VS 9.43% | Results | POSITIVE | Margin expansion, operational leverage | |
| 212 | 2026-05-20 | 19:28:26 | — | 2026-05-20 | 19:28:26 | COSMO FIRST | Q4 CONS NET PROFIT 369M VS 271M (YOY), REVENUE 10B VS 7.46B | Results | BUY | Profit +36%, revenue growth |
| # | SS Date | SS Time | Ago | Actual Date | Actual Time | Company | News | Category | CMP | Action/View | Analysis/Notes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 221 | 2026-05-20 | 19:28:52 | 33m ago | 2026-05-20 | 18:55:52 | APOLLO HOSPITALS ENTERPRISE | Q4 EBITDA 10.1B RUPEES VS 7.7B (YOY), EBITDA MARGIN 15.31% | Results | POSITIVE | EBITDA growth, margin improvement | |
| 222 | 2026-05-20 | 19:29:00 | — | 2026-05-20 | 19:29:00 | APOLLO HOSPITALS ENTERPRISE | Final dividend of 10 rupees per share | Dividend | POSITIVE | Dividend announced, shareholder return | |
| 223 | 2026-05-20 | 19:28:52 | — | 2026-05-20 | 19:28:52 | APOLLO HOSPITALS ENTERPRISE | Q4 CONS NET PROFIT 5.3B VS 3.9B (YOY), REVENUE 66B | Results | BUY | Net profit +36% YoY |
| # | SS Date | SS Time | Ago | Actual Date | Actual Time | Company | News | Category | CMP | Action/View | Analysis/Notes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 231 | 2026-05-20 | 19:29:26 | 1h ago | 2026-05-20 | 18:29:26 | BOSCH | Q4 EBITDA 7.8B RUPEES VS 6.5B (YOY), EBITDA MARGIN 14% VS 13.17% | Results | POSITIVE | Margin expansion, healthy EBITDA | |
| 232 | 2026-05-20 | 19:29:26 | 1h ago | 2026-05-20 | 18:29:26 | BOSCH | Final dividend of 270 rupees per share | Dividend | POSITIVE | High dividend payout | |
| 233 | 2026-05-20 | 19:29:26 | 1h ago | 2026-05-20 | 18:29:26 | BOSCH | Q4 SL NET PROFIT 5.7B VS 5.5B (YOY), REVENUE 55.6B VS 49B | Results | HOLD | Modest profit growth, revenue up |
| # | SS Date | SS Time | Ago | Actual Date | Actual Time | Company | News | Category | CMP | Action/View | Analysis/Notes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 241 | 2026-05-20 | 19:32:03 | 3h ago | 2026-05-20 | 16:32:03 | LENSKART SOLUTIONS | Q4 EBITDA 5.4B VS 2.9B (YOY), MARGIN 21.4% VS 17% | Results | BUY | Strong margin expansion & EBITDA growth | |
| 242 | 2026-05-20 | 19:34:45 | — | 2026-05-20 | 19:34:45 | LENSKART SOLUTIONS | Q4 REVENUE 25B VS 17.3B (YOY) | Results | POSITIVE | Revenue jump +44% | |
| 243 | 2026-05-20 | 19:34:45 | — | 2026-05-20 | 19:34:45 | LENSKART SOLUTIONS | Q4 CONS NET PROFIT 2B VS 2.2B (YOY) | Results | HOLD | Profit slightly dips despite revenue growth |
| # | SS Date | SS Time | Ago | Actual Date | Actual Time | Company | News | Category | CMP | Action/View | Analysis/Notes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 251 | 2026-05-20 | 19:31:39 | 3h ago | 2026-05-20 | 16:31:39 | Eris Lifescience | FY27 Revenue Growth Guidance Of 18-20% | Guidance | BUY | Strong double-digit growth outlook | |
| 252 | 2026-05-20 | 19:35:17 | — | 2026-05-20 | 19:35:17 | ERIS LIFESCIENCE | Q4 EBITDA 2.73B VS 2.52B (YOY), MARGIN 36.2% VS 35.78% | Results | POSITIVE | Margin improvement, steady EBITDA |
;->CAUTION
| # | SS Date | SS Time | Ago | Actual Date | Actual Time | Company | News | Category | CMP | Action/View | Analysis/Notes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 261 | 2026-05-20 | 19:31:47 | — | 2026-05-20 | 19:31:47 | OLA ELECTRIC MOBILITY | Q4 REVENUE 2.6B VS 6B (YOY) | Results | CAUTION | Revenue decline steep | |
| 262 | 2026-05-20 | 19:31:47 | — | 2026-05-20 | 19:31:47 | OLA ELECTRIC MOBILITY | Q4 EBITDA LOSS 2.8B VS LOSS 7B (YOY) | Results | Losses narrow but revenue weak | ||
| 263 | 2026-05-20 | 19:32:03 | 3h ago | 2026-05-20 | 16:32:03 | OLA ELECTRIC MOBILITY | Q4 CONS NET LOSS 5B VS LOSS 9B (YOY) | Results | CAUTION | Net loss still high, concern |
| # | SS Date | SS Time | Ago | Actual Date | Actual Time | Company | News | Category | CMP | Action/View | Analysis/Notes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 271 | 2026-05-20 | 19:31:04 | — | 2026-05-20 | 19:31:04 | Jubilant Foodworks | Co expects Q1 FY27 growth to surpass Q4 FY26 performance | Guidance | POSITIVE | Positive near-term growth outlook | |
| 272 | 2026-05-20 | 19:31:12 | — | 2026-05-20 | 19:31:12 | JUBILANT FOODWORKS | Q4 CONS NET PROFIT 800M VS 480M (YOY), REVENUE 25B | Results | BUY | Profit +67%, revenue momentum | |
| 273 | 2026-05-20 | 19:31:30 | — | 2026-05-20 | 19:31:30 | JUBILANT FOODWORKS | Q4 EBITDA 4.85B VS 3.9B (YOY), MARGIN 19.4% VS 18.51% | Results | POSITIVE | Margin expansion, EBITDA growth |
Logged out — showing 362 public records only. Login to see 382 private items.
No memories match this filter.
Jump to detailed list ↓ · 362 clickable cards
Comments (0)
No comments yet. Be the first to share your thoughts!